Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An uncommon intraepithelial malignant neoplasm of eccrine or apocrine origin, arising from the vulva. It usually affects post-menopausal women. In approximately 10-20% of the cases there is an associated anorectal, or urothelial carcinoma or a skin appendage adenocarcinoma identified. It presents as a red, eczematous lesion. Microscopically, it is characterized by the presence of the typical Paget cells which are large, round cells with abundant cytoplasm and prominent nuclei.
Biomarker and diagnostic research for vulval Paget disease has been reported in the published literature.
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
10 publications have been identified in PubMed for vulval Paget disease. Research spans Diagnostic / Biomarker (40%), Case Report / Case Series (40%), and Review / Meta-Analysis (10%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 4 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
Patient case studies | 4 | 40% |
Research summaries | 1 | 10% |
Disease patterns and progression | 1 | 10% |
Jeffus SK (2026). [PMID: 41997580](https://pubmed.ncbi.nlm.nih.gov/41997580/). *Int J Gynecol Pathol*. [Diagnostic / Biomarker]
Luo Y (2026). [PMID: 41421463](https://pubmed.ncbi.nlm.nih.gov/41421463/). *J Am Acad Dermatol*. [Diagnostic / Biomarker]
Claus J (2026). [PMID: 41561668](https://pubmed.ncbi.nlm.nih.gov/41561668/). *Gynecologic oncology reports*. [Case Report / Case Series]
Chung JG (2025). [PMID: 39400876](https://pubmed.ncbi.nlm.nih.gov/39400876/). *International journal of dermatology*. [Review / Meta-Analysis]
Clemente N (2025). [PMID: 41176833](https://pubmed.ncbi.nlm.nih.gov/41176833/). *International journal of gynecological cancer : official journal of the International Gynecological Cancer Society*. [Diagnostic / Biomarker]
Tsukada H (2025). [PMID: 41029188](https://pubmed.ncbi.nlm.nih.gov/41029188/). *Hinyokika kiyo. Acta urologica Japonica*. [Case Report / Case Series]
Sittiwong W (2024). [PMID: 39943969](https://pubmed.ncbi.nlm.nih.gov/39943969/). *Journal of contemporary brachytherapy*. [Case Report / Case Series]
Coffey-Noriega E (2024). [PMID: 39376713](https://pubmed.ncbi.nlm.nih.gov/39376713/). *Gynecologic oncology reports*. [Epidemiology / Natural History]
Chung JG (2024). [PMID: 38545867](https://pubmed.ncbi.nlm.nih.gov/38545867/). *Journal of the European Academy of Dermatology and Venereology : JEADV*. [Case Report / Case Series]
Della Corte L (2024). [PMID: 38978790](https://pubmed.ncbi.nlm.nih.gov/38978790/). *Pathology oncology research : POR*. [Diagnostic / Biomarker]